1 An elderly hypertensive woman developed severe renal failure owin hydralazine-induced lupus, although the dose never exceeded 150 mg da
2 Renal biopsy appearances were consistent with an immune-comp mediated glomerulonephritis.
3 Withdrawal of the drug was followed by rapid recovery in spite structural damage to the kidney.
Get full access to this article
View all access options for this article.
References
1.
Alarcon-Segovia, D. , Wakin, K.G., Worthington, J.W. & Ward, L.E. (1967). Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine, 46, 1-33.
2.
Boman, G. (1978). Hydralazine-induced lupus, reported to the Swedish Adverse Drug Reaction Committee. CIBA Symposium, 147-152.
3.
Dubois, E.L. & Tuffanelli, D.L. (1964). Clinical manifestations of systemic lupus erythematosus: computer analysis of 520 cases. J. Am. Med. Ass., 190, 104.
4.
Hughes, G.R.V. (1979). The connective tissue diseases. Medicine 3rd series, 13,639-643.
5.
Levo et al. (1976). Pathological features of lupus nephritis. Ann. Rheum. Dis. , 35,181-185.
6.
Perry, H.M. , Tan, E.M., Carmody, S. & Sakamoto, A. (1970). Relationship of acetyl transferase activity to antinuclear antibodies and toxic-symptoms in hypertensive patients treated with hydralazine. J. Lab. Clin. Med., 76, 114.
